CP is commonly given by the intravenous route and upon its absorption into cancer cells, it interacts with macromolecules in the cell and exerts cytotoxicity via binding to DNA and forming adducts with subsequent suppression of DNA synthesis and cellular division. Here, CP is linked to cancer.